01st week of 2014 patent applcation highlights part 42 |
Patent application number | Title | Published |
20140004101 | SMAC PEPTIDOMETICS USEFUL AS IAP INHIBITORS | 2014-01-02 |
20140004102 | Methods for treating and/or limiting development of diabetes | 2014-01-02 |
20140004103 | Method of treating malignant mesothelioma | 2014-01-02 |
20140004104 | COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH AN ANTI-BCL-2 ACTIVE AGENT | 2014-01-02 |
20140004105 | AGE-RELATED MACULAR DEGENERATION DIAGNOSTICS | 2014-01-02 |
20140004106 | STABLE IGG4 BASED BINDING AGENT FORMULATIONS | 2014-01-02 |
20140004107 | ST2 ANTIGEN BINDING PROTEINS | 2014-01-02 |
20140004108 | Methods for Modulation of Autophagy Through the Modulation of Autophagy-Enhancing Gene Products | 2014-01-02 |
20140004109 | Methods Of Reducing Eosinophil Levels | 2014-01-02 |
20140004110 | ANTI CD37 ANTIBODIES | 2014-01-02 |
20140004111 | POLYCYCLIC AGENTS FOR THE TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS INFECTIONS | 2014-01-02 |
20140004112 | Therapeutic Peptides | 2014-01-02 |
20140004113 | DEFENSIN-ANTIGEN FUSION PROTEINS | 2014-01-02 |
20140004114 | STABLE AND SOLUBLE ANTIBODIES INHIBITING VEGF | 2014-01-02 |
20140004115 | METHODS OF PREVENTING OR TREATING PAIN USING ANTI-NGF ANTIBODIES THAT SELECTIVELY INHIBIT THE ASSOCIATION OF NGF WITH TRKA, WITHOUT AFFECTING THE ASSOCIATION OF NGF WITH P75 | 2014-01-02 |
20140004116 | METHODS OF PREVENTING OR TREATING PAIN USING ANTI-NGF ANTIBODIES | 2014-01-02 |
20140004117 | B-CELL REDUCTION USING CD37-SPECIFIC AND CD20-SPECIFIC BINDING MOLECULES | 2014-01-02 |
20140004118 | CLOSTRIDIUM DIFFICILE ANTIBODIES | 2014-01-02 |
20140004119 | AGONISTIC ANTIBODIES TO TRKC RECEPTORS AND USES THEREOF | 2014-01-02 |
20140004120 | NOVEL ANTI-DR5 ANTIBODY | 2014-01-02 |
20140004121 | ANTI-MESOTHELIN BINDING PROTEINS | 2014-01-02 |
20140004122 | METHODS FOR TREATING OR PREVENTING CHOLESTEROL RELATED DISORDERS | 2014-01-02 |
20140004123 | MONOCLONAL ANTIBODY PRODUCTION BY EBV TRANSFORMATION OF B CELLS | 2014-01-02 |
20140004124 | MONOCLONAL ANTIBODIES FOR CSPG4 FOR THE DIAGNOSIS AND TREATMENT OF BASAL BREAST CARCINOMA | 2014-01-02 |
20140004125 | IL-1BETA BINDING ANTIBODIES AND FRAGMENTS THEREOF | 2014-01-02 |
20140004126 | THERAPY AND METHOD FOR INTRATUMORALLY INTRODUCING CYTOTOXIC T LYMPHOCYTE AND/OR NKT CELL WITH ANTI-TNF AND/OR ANTI-IL-10 | 2014-01-02 |
20140004127 | Human Anti-IFN-gamma Neutralizing Antibodies as Selective IFN-gamma Pathway Inhibitors | 2014-01-02 |
20140004128 | ANTI-IL-18 ANTIBODIES AND THEIR USES | 2014-01-02 |
20140004129 | Novel Polypeptides Involved in Immune Response | 2014-01-02 |
20140004130 | MIA (Melanoma Inhibitory Activity) Inhibitors for Detecting, Preventing and Curing Vitiligo | 2014-01-02 |
20140004131 | ANTIBODY FORMULATION | 2014-01-02 |
20140004132 | IMMUNOTHERAPY OF CANCER USING GENETICALLY ENGINEERED GD2-SPECIFIC T CELLS | 2014-01-02 |
20140004133 | TREATMENT METHOD FOR RELAPSING-REMITTING MULTIPLE SCLEROSIS | 2014-01-02 |
20140004134 | NF-KB SIGNALING PATHWAY-MANIPULATED DENDRITIC CELLS | 2014-01-02 |
20140004135 | YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS | 2014-01-02 |
20140004136 | PHOSPHORYLATED DERIVATIVES OF A U1-70K PEPTIDE AND THEIR USE IN THE TREATMENT OF AUTOIMMUNE PATHOLOGIES | 2014-01-02 |
20140004137 | IMMUNE RESTRICTED PEPTIDES WITH INCREASED EFFICACY | 2014-01-02 |
20140004138 | DETOXIFIED PNEUMOCOCCAL NEURAMINIDASE AND USES THEREOF | 2014-01-02 |
20140004139 | SEROLOGIC CORRELATES OF PROTECTION AGAINST BACILLIS ANTHRACIS INFECTION | 2014-01-02 |
20140004140 | GROUP B STREPTOCOCCUS VACCINE | 2014-01-02 |
20140004141 | Methods And Compositions Of Protein Antigens For The Diagnosis And Treatment Of Toxoplasma Gondii Infections And Toxoplasmosis | 2014-01-02 |
20140004142 | PCSK9 VACCINE | 2014-01-02 |
20140004143 | ADENO-ASSOCIATED VIRUS (AAV) SEROTYPE 8 SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREFOR | 2014-01-02 |
20140004144 | Attenuated Streptococcus suis Vaccines and Methods of Making and Use Thereof | 2014-01-02 |
20140004145 | PURIFICATION OF VIRUS LIKE PARTICLES | 2014-01-02 |
20140004146 | METHOD FOR PRODUCING VIRUS-LIKE PARTICLE BY USING DROSOPHILA CELL AND APPLICATIONS THEREOF | 2014-01-02 |
20140004147 | ANTIGENIC CHIMERIC TICK-BORNE ENCEPHALITIS VIRUS/DENGUE VIRUS TYPE 4 RECOMBINANT VIRUSES | 2014-01-02 |
20140004148 | Methods and Compositions for Inhibiting Diseases of the Central Nervous System | 2014-01-02 |
20140004149 | Immunogenic Influenza Composition | 2014-01-02 |
20140004150 | Vaccine Injection, Preparation Method and Use Thereof | 2014-01-02 |
20140004151 | Antigens and Epitopes Derived From Mycobacterium Tuberculosis | 2014-01-02 |
20140004152 | MILK-BASED PROTEIN HYDROLYSATES AND INFANT FORMULAE AND NUTRITIONAL COMPOSITIONS MADE THEREOF | 2014-01-02 |
20140004153 | USE OF SOMATIC MUTATIONS IN THE EXTRACELLULAR DOMAIN OF TRANSMEMBRANE PROTEINS IN A PATIENT'S TUMOR AS IMMUNOGENS FOR ACTIVE HUMORAL IMMUNOTHERAPY OF CANCER | 2014-01-02 |
20140004154 | Pharmaceutical Composition Consisting Of RNA Having Alkali Metal As Counter Ion And Formulated With Dications | 2014-01-02 |
20140004155 | 2-AMINOTHIAZOLE DERIVATIVES AND METHODS OF PREPARING AND USING THE SAME | 2014-01-02 |
20140004156 | BIOLOGICAL INHIBITORS OF ROR1 CAPABLE OF INDUCING CELL DEATH | 2014-01-02 |
20140004157 | AGENT FOR DELAYING DIGESTION AND ABSORPTION OF LIPID | 2014-01-02 |
20140004158 | CELL ATTACHMENT COATINGS AND METHODS USING PHOSPHOROUS-CONTAINING PHOTOREAGENT | 2014-01-02 |
20140004159 | NANOFIBER SCAFFOLDS AND METHODS FOR REPAIRING SKIN DAMAGE | 2014-01-02 |
20140004160 | ORALLY EFFECTIVE METHYLPHENIDATE EXTENDED RELEASE POWDER AND AQUEOUS SUSPENSION PRODUCT | 2014-01-02 |
20140004161 | BONE SUBSTITUTE COMPOSITIONS, METHODS OF PREPARATION AND CLINICAL APPLICATIONS | 2014-01-02 |
20140004162 | Transfer Resistant Cosmetic | 2014-01-02 |
20140004163 | DISPERSIBLE MOIST WIPE WITH EMULSION FOR PREVENTION OF SKIN IRRITATION | 2014-01-02 |
20140004164 | Stable Emulsion for Prevention of Skin Irritation and Items Using Same | 2014-01-02 |
20140004165 | BASE FORMULATION FOR COSMETIC PRODUCTS | 2014-01-02 |
20140004166 | Stable Emulsion for Prevention of Skin Irritation and Articles Using Same | 2014-01-02 |
20140004167 | PESTICIDAL COMPOSITION COMPRISING SULPHUR, ACARICIDE AND AN AGROCHEMICAL EXCIPIENT | 2014-01-02 |
20140004168 | ROOFING GRANULES | 2014-01-02 |
20140004169 | LOCAL VASCULAR DELIVERY OF TRICHOSTATIN A ALONE OR IN COMBINATION WITH SIROLIMUS TO PREVENT RESTENOSIS FOLLOWING VASCULAR INJURY | 2014-01-02 |
20140004170 | COATING OF A DRUG-ELUTING MEDICAL DEVICE | 2014-01-02 |
20140004171 | TREATMENT OF ENDOMETRIOSIS BY INTRAVAGINAL ADMINISTRATION OF A LOW DOSE OF A SELECTIVE PROGESTERONE RECEPTOR MODULATOR (SPRM), ANTI-PROGESTIN, OR ANTI-PROGESTATIONAL AGENT | 2014-01-02 |
20140004172 | LIPOSOMES ACTIVE IN-VIVO ON NEURODEGENERATIVE DISEASES | 2014-01-02 |
20140004173 | PRODUCTION OF MULTIVESICULAR LIPOSOMES | 2014-01-02 |
20140004174 | SELECTIVE INHIBITORS OF HISTONE DEACETYLASE | 2014-01-02 |
20140004175 | ANGIOPOIETIN DERIVED PEPTIDES | 2014-01-02 |
20140004176 | DELIVERY OF TREATMENTS TRANSDERMALLY FOR FUNGAL INFECTIONS AND OTHER INDICATIONS | 2014-01-02 |
20140004177 | COX-2 INHIBITORS AND RELATED COMPOUNDS, AND SYSTEMS AND METHODS FOR DELIVERY THEREOF | 2014-01-02 |
20140004178 | OMV VACCINE AGAINST BURKHOLDERIA INFECTIONS | 2014-01-02 |
20140004179 | COMPOSITION COMPRISING DIAMINE OXIDASE FOR USE IN THE TREATMENT OR PREVENTION OF FIBROMYALGIA OR CHRONIC FATIGUE SYNDROME | 2014-01-02 |
20140004180 | TOPICAL COMPOSITIONS COMPRISING DIAMINOOXIDASE FOR THE TREATMENT OR PREVENTION OF DISEASES ASSOCIATED WITH HIGH HISTAMINE LEVELS WHICH INVOLVE AN INCREASE IN PAIN | 2014-01-02 |
20140004181 | COMPOSITIONS AND METHODS FOR EXOSOME TARGETED EXPRESSION | 2014-01-02 |
20140004182 | METHODS FOR THE TREATMENT OF SARCOIDOSIS | 2014-01-02 |
20140004183 | METHODS FOR TREATING CARDIOVASCULAR DISEASE IN STATIN-TOLERANT SUBJECTS | 2014-01-02 |
20140004184 | COATED TABLET FORMULATIONS AND USES THEREOF | 2014-01-02 |
20140004185 | PHARMACEUTICAL COMPOSITION | 2014-01-02 |
20140004186 | COMPOSITIONS COMPRISING A FATTY ACID OIL MIXTURE COMPRISING EPA AND DHA IN FREE ACID FORM, A SURFACTANT, AND A STATIN | 2014-01-02 |
20140004187 | Capsule pharmaceutical dosage form comprising a suspension formulation of an indolinone derivative | 2014-01-02 |
20140004188 | CRYSTAL FORMS OF (R)-N-METHYLNALTREXONE BROMIDE AND USES THEREOF | 2014-01-02 |
20140004189 | MODIFIED RELEASE PHARMACEUTICAL COMPOSITIONS MEMANTINE | 2014-01-02 |
20140004190 | Solid Dosage Forms of Bendamustine | 2014-01-02 |
20140004191 | MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION | 2014-01-02 |
20140004192 | PHARMACEUTICAL FORMULATIONS OF INDIBULIN AND USES THEREOF | 2014-01-02 |
20140004193 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME | 2014-01-02 |
20140004194 | HIGHLY STABLE COLLOID FROM AQUEOUS SOLUTIONS OF SMALL ORGANIC MOLECULES | 2014-01-02 |
20140004195 | MEDICATED PARTICUALTE ANIMAL FEED SUPPLEMENTS AND METHODS OF PREPARATION | 2014-01-02 |
20140004196 | POLYAMIDE-AMINE DENDRIMER OR DERIVATIVE THEREOF-MATH1 GENE NANO PARTICLE AND USE THEREOF IN TREATMENT OF HEARING LOSS | 2014-01-02 |
20140004197 | O/W-EMULSIONS COMPRISING SEMIFLUORINATED ALKANES | 2014-01-02 |
20140004198 | GLP-1 PARTICLES AND COMPOSITIONS | 2014-01-02 |
20140004199 | DRUG CARRIER FOR TUMOR-TARGETED THERAPY, ITS PREPARATION METHOD AND ITS USE | 2014-01-02 |
20140004200 | POLYMER COMPOSITIONS WITH BIOACTIVE AGENT, MEDICAL ARTICLES, AND METHODS | 2014-01-02 |